A photo of Irina Rybalsky.

Irina Rybalsky, MD, PhD


  • Neuromuscular Specialist, Division of Neurology
  • Staff Physician, Division of Neurology

About

Additional Languages

Russian

Location

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Emergency Planning as Part of Healthcare Transition Preparation for Patients with Duchenne Muscular Dystrophy. Chouteau, WA; Burrows, C; Wittekind, SG; Rutter, MM; Bange, JE; Sabla, GE; Rybalsky, I; Tian, C. Journal of Pediatric Nursing. 2021; 61:298-304.

DMD – CLINICAL CARE EP.101 Appendicular lean mass index (ALMI) changes in patients with dystrophinopathies. Wong, B; Summer, S; Horn, P; Rutter, M; Tian, C; Rybalsky, I; Shellenbarger, K; Kalkwarf, H. Neuromuscular Disorders. 2021; 31.

DMD - TREATMENT EP.143 Assessment of patients on Eteplirsen (Exondys 51) therapy using real world data. Zygmunt, A; Rybalsky, I; Chouteau, W; Horn, P; Tian, C. Neuromuscular Disorders. 2021; 31.

Age-related changes in appendicular lean mass in males with Duchenne muscular dystrophy: A retrospective review. Summer, SS; Wong, BL; Rutter, MM; Horn, PS; Tian, C; Rybalsky, I; Shellenbarger, KC; Kalkwarf, HJ. Muscle and Nerve. 2021; 63:231-238.

Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy. Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; et al. Osteoporosis International. 2020; 31:2449-2459.

Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Rybalsky, I; Shellenbarger, KC; Rutter, MM. Neuromuscular Disorders. 2020; 30:599-610.

Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Darmahkasih, AJ; Rybalsky, I; Tian, C; Shellenbarger, KC; Horn, PS; Lambert, JT; Wong, BL. Muscle and Nerve. 2020; 61:466-474.

MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy. Naarding, KJ; Reyngoudt, H; van Zwet, EW; Hooijmans, MT; Tian, C; Rybalsky, I; Shellenbarger, KC; Le Louer, J; Wong, BL; Carlier, PG; et al. Neurology. 2020; 94:e1386-e1394.

Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy. Lambert, JT; Darmahkasih, AJ; Horn, PS; Rybalsky, I; Shellenbarger, KC; Tian, C; Wong, BL. Muscle and Nerve. 2020; 61:156-162.

Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy. Sawnani, H; Horn, PS; Wong, B; Darmahkasih, A; Rybalsky, I; Shellenbarger, KC; Tian, C; Rutter, MM; Simakajornboon, N; Amin, R; et al. Journal of Pediatrics. 2019; 210:194-200.e2.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey